CCR5 and HIV-1 infection: This knockdown inhibited HIV-1 infection, as illustrated by the decrease in eGFP-positive cells upon infection with a CCR5-tropic HIV-1 virus encoding eGFP (NL4-3-Bal-IRES-eGFP) (Fig. 1B).